BRCA1 and breast carcinoma: However, given that the prevalence of BRCA1/2 mutations is estimated to be 1:400–1:500 in the general population [32,33] and 1:30–1:40 in the average breast cancer patient [34], it can be concluded that the vast majority of these patients are BRCA1/2-mutation-negative.